
Sign up to save your podcasts
Or
In today’s broadcast, we look back at the top stories from the first half of 2024. There were several advancements made during the first six months., including the approval of an excimer laser platform; the global adoption of sustained-released anti-VEGF treatments for retinal diseases; the rollout of autonomous AI screening technology; and a total solar eclipse.
Learn more about your ad choices. Visit megaphone.fm/adchoices
In today’s broadcast, we look back at the top stories from the first half of 2024. There were several advancements made during the first six months., including the approval of an excimer laser platform; the global adoption of sustained-released anti-VEGF treatments for retinal diseases; the rollout of autonomous AI screening technology; and a total solar eclipse.
Learn more about your ad choices. Visit megaphone.fm/adchoices